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Activation of GABAA receptors (GABAARs) produces two forms of inhibition: phasic inhibition generated by the rapid, transient activa-
tion of synaptic GABAARs by presynaptic GABA release, and tonic inhibition generated by the persistent activation of perisynaptic or
extrasynaptic GABAARs, which can detect extracellular GABA. Such tonic GABAAR-mediated currents are particularly evident in dentate
granule cells in which they play a major role in regulating cell excitability. Here we show that in rat dentate granule cells in ex vivo
hippocampal slices, tonic currents are predominantly generated by GABA-independent GABAA receptor openings. This tonic GABAAR
conductance is resistant to the competitive GABAAR antagonist SR95531 (gabazine), which at high concentrations acts as a partial
agonist, but can be blocked by an open channel blocker, picrotoxin. When slices are perfused with 200 nM GABA, a concentration
that is comparable to CSF concentrations but is twice that measured by us in the hippocampus in vivo using zero-net-flux
microdialysis, negligible GABA is detected by dentate granule cells. Spontaneously opening GABAARs, therefore, maintain dentate
granule cell tonic currents in the face of low extracellular GABA concentrations.
Introduction
In addition to fast synaptic GABAA receptor (GABAAR)-
mediated signaling, there is a slower form of signaling resulting
from the tonic activation of GABAARs (Semyanov et al., 2004;
Farrant and Nusser, 2005; Glykys and Mody, 2007a). Tonically
activeGABAARs can have profound effects on neuronal excitabil-
ity, synaptic plasticity, network oscillations, and neurogenesis
(Ge et al., 2006; Pavlov et al., 2009; Holter et al., 2010; Mann and
Mody, 2010; Martin et al., 2010; Duveau et al., 2011) and have
been implicated in neuronal development, information process-
ing, cognition, and memory (Semyanov et al., 2004; Farrant and
Nusser, 2005; Brickley and Mody, 2012). The conventional view
is that tonic currents are mediated by high-affinity extrasynaptic
GABAARs that can detect low concentrations of ambient GABA,
and therefore the magnitude of tonic currents is regulated by the
expression of these receptors and the availability of extracellular
GABA (Semyanov et al., 2004; Farrant and Nusser, 2005; Glykys
and Mody, 2007a).
The sources and concentration of extracellular GABA
([GABA]e) are, however, still debated. Vesicular release, “leak”
through bestrophin channels, and reversal of GABA transporters
have all been suggested to contribute to the extracellular GABA
pool (Attwell et al., 1993; Gaspary et al., 1998; Lee et al., 2010). In
vivo estimates indicate that [GABA]e is in the micromolar or
submicromolar range (Lerma et al., 1986; Kuntz et al., 2004;
Nyitrai et al., 2006). In vitro studies have suggested even lower
concentrations of GABA, in the nanomolar range; indeed, active
uptakemaintainsGABAat sufficiently low concentrations to pre-
vent tonic GABAB receptor activation (Isaacson et al., 1993).
Thus, tonic currents in hippocampal neurons have often been
measured in conditions that artificially raise [GABA]e by inhib-
iting GABA uptake or metabolism, or by adding exogenous
GABA to the perfusate (Overstreet andWestbrook, 2001; Nusser
andMody, 2002; Stell andMody, 2002;Holter et al., 2010).When
GABA is not increased by these means, various magnitudes of
tonic currents have been obtained using different GABAAR an-
tagonists (Bai et al., 2001; Mtchedlishvili and Kapur, 2006; Zhan
and Nadler, 2009; Mtchedlishvili et al., 2010). Here we report a
novel form of tonic inhibition mediated by GABA-independent
openings of GABAARs, which can explain these discrepancies.
We focus on dentate gyrus granule cells (DGCs), the excitabil-
ity of which critically depends upon the presence of tonic
GABAAR-mediated conductances (Overstreet and Westbrook,
2001; Nusser andMody, 2002; Stell andMody, 2002; Coulter and
Carlson, 2007; Holter et al., 2010). We demonstrate that under
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baseline conditions, or when the perfusate contains the same
concentration of GABA that is found in CSF, the major con-
tributors to the tonic current in DGCs are spontaneously
opening GABAARs. This tonic GABAAR conductance is resis-
tant to the competitive GABAAR antagonist gabazine
(SR95531), but can be blocked by an open channel blocker,
picrotoxin. On increasing [GABA]e, a SR95531-sensitive com-
ponent of tonic current emerges. Together, these results indi-
cate that the GABA-independent component of tonic current
mediated by spontaneously opening GABAARs maintains
tonic inhibition in the presence of low extracellular GABA
concentrations measured in vivo.
Materials andMethods
Hippocampal slice preparation
Transverse hippocampal slices (350 m thick) were used for in vitro
electrophysiological recordings. Slices were prepared from 3- to 4-week-
old male Sprague Dawley rats and / knockouts or / littermate
control mice on a C57B6 background (Mihalek et al., 1999; Herd et al.,
2008). Animals were killed by an overdose of isoflurane according to the
United Kingdom Animals (Scientific Procedures) Act of 1986. After de-
capitation, brains were rapidly removed and dissected, and hippocampi
were sliced with a Leica VT1200S vibratome in ice-cold sucrose-based
solution containing the following (in mM): 70 sucrose, 80 NaCl, 2.5 KCl,
7MgCl2, 0.5 CaCl2, 25NaHCO3, 1.25NaH2PO4, 22 glucose, equilibrated
with 95% O2 plus 5% CO2, pH 7.4, 315–330 mOsm. Slices were main-
tained in continuously oxygenated sucrose-free storage solution at 33°C
for 15 min, equilibrated to a room temperature for 15 min and then
placed to recover in continuously oxygenated humid interface holding
chamber at room temperature for at least 1 h before recording. In exper-
iments with concanamycin, slices were prepared in exactly the same way,
but before placing them in a holding chamber for the recovery they were
incubated for 2 h in a submerged chamberwith continuously oxygenated
storage solution and 0.5M concanamycin. After that, slices were placed
in an interface holding chamber and allowed to rest for about half an
hour before recording. After recovering slices were transferred into re-
cording chamber. The perfusion and storage medium contained the fol-
lowing (inmM): 119NaCl, 2.5 KCl, 1.3MgSO4, 2.5 CaCl2, 26.2NaHCO3,
1NaH2PO4, 22 glucose andwas gassedwith 95%O2 and 5%CO2, pH7.4;
290–298 mOsm.
In vitro electrophysiology
Whole-cell recordings.Visualized patch-clamp recordings frommature den-
tate granule cells (input resistance, Rin 310 50M; membrane capaci-
tance, Cm  48  6 pF) were performed using an infrared differential
interference contrast imaging system. Tonic GABAAR-mediated currents
were measured in voltage-clamp mode (at holding potential Vhold 
70mV) in the presence of ionotropic glutamate receptor blockers DL-APV
(50 M) and NBQX (20 M), metabotropic glutamate receptors blocker
(S)--methyl-4-carboxyphenylglycine (MCPG; 250 M), and GABAB re-
ceptor blocker (2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hy-
droxypropyl](phenylmethyl)phosphinic acid (CGP55845; 1 M). The
intracellular pipette solution contained the following (mM): 120.5 CsCl, 10
KOH-HEPES, 2EGTA,8NaCl, 5QX-314Br salt, 2Mg-ATP, 0.3Na-GTP,
10 Na-phosphocreatine, pH adjusted to 7.2 and osmolarity adjusted to 295
mOsm. The tonic GABAAR-mediated current wasmeasured as an outward
shift in holding current following application of picrotoxin (100 M).
Changes in rootmean square (RMS)noisehave alsobeenproposed to reflect
changes in tonic GABAAR-mediated conductances and have been used be-
cause they are unaffected by current drift. AlthoughRMSnoise decreased in
experiments inwhich tonic currentswere blocked, thismeasurement is con-
founded by the presence of synaptic currents.Moreover, RMS noise is non-
linearly related to current and can paradoxically decrease when tonic
currents increase (Traynelis and Jaramillo, 1998; Glykys andMody, 2007a).
We, therefore, onlyusedRMSnoise as ameasure inexperiments inwhichwe
were trying to block the tonic current. Three other GABAAR antagonists,
bicucullinemethiodide (BMI) (10M), SR95531 (0.5, 25, and 125M), and
pentylenetetrazol (1.5mM)wereused in experiments.Gabazine (25M)and
bicuculline (10M) were used at concentrations that would be predicted to
give 90% occupancy of GABAARs in dentate granule cells (Jones et al.,
2001). The affinity of gabazine for GABAARs in dentate granule cells is an
order of magnitude greater than that of bicuculline (Jones et al., 2001), so
that equimolar concentrations of gabazine displace bicuculline from its
binding site. Glycine receptors were blocked with 1 M strychnine, GABAC
receptors—with 50 M (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic
acid (TPMPA). Recordings were performed at 32–34°C. The whole-cell pi-
pette resistance was 4–5.5M. Series resistance wasmonitored throughout
experiments using a5mV step command. Cells showing a20% change
in a series resistance, a resistance20M, or unstable holding currentwere
rejected.
Acquisition and analysis. Recordings were obtained using a Multi-
Clamp 700B or Axopatch 200B amplifier (Molecular Devices), filtered at
4 kHz, digitized at 10 kHz, and stored on a PC. WinEDR (Strathclyde
Electrophysiology Software) was used for data acquisition and pClamp
(MolecularDevices), andOriginPro 8.1 (OriginLab) for off-line analysis.
For analysis of tonic currents, mean values of holding current during
200 ms epochs free of synaptic currents were measured every 30 s. The
amplitude of the tonic current was calculated as the difference between
the holding current (Ihold) measured 6 min before and 10 min after the
application of an antagonist. The speed of perfusion in our system of 3.5
ml/min allowed full equilibration of the solution in the recording cham-
ber at this time point. The values of RMSnoisewere calculated for 200ms
epochs free of synaptic events. The change of RMS noise (rms) was
calculated as the difference between the values before and after the
application of an antagonist.
Outside-out and nucleated patch recordings. GABAAR-mediated cur-
rents were recorded in the presence of 0.1MCGP55845, 100MD-APV,
10 M NBQX, 200 M S-MCPG, and 1 M strychnine. The intracellular
pipette solution contained the following (in mM): 120.5 CsCl, 10 KOH-
HEPES, 10 BAPTA, 8 NaCl, 5 QX-314 Br salt, 2 Mg-ATP, 0.3 Na-GTP,
pH 7.2, osmolarity 295mOsm. Patches were pulled fromdentate granule
cells, and recordings were performed in voltage-clampmode at 33–34°C
(Vhold70 mV) using MultiClamp 700B amplifier. Signals were dig-
itized at 10 kHz. The patch pipette resistance was 5–7 M.
For the rapid solution exchange we used a -glass application pipette
with200 m tip diameter attached to the micromanipulator. The po-
sition of the pipette was controlled by piezoelectric element (the speed of
switchwas 50–100s).One pipette channelwas filledwith the bath aCSF
solution or bath solution plus 10 M GABA; another channel had 10 M
GABA, 25 or 125 M SR95531, 10 M bicuculline, or 20 M picrotoxin.
Pressure was regulated by a PDES-02DX pneumatic micro ejector (npi)
using compressed nitrogen separately in each of two channels. Solutions
with SR95531, bicuculline, and picrotoxin were exchanged in a pipette
channel (7–12 s) during the exposure of nucleated patch to the bath
solution channel (Bennett and Kearns, 2000; Sylantyev et al., 2008).
Analysis of the single-channel recordings
All analyses were performed on stretches of data that were longer than 3min.
The opening frequency of GABAAR-mediated channels was calculated as
N/t, whereN is the number of openings andt is the time of recording.
N was counted using a detection threshold of 1.5 pA more negative than
mean baseline and a minimum opening time of 0.2 ms. To calculate
single-channel conductance and average open time, we first built
all-points amplitude histograms and fitted them with a two-Gaussian
function:
F 
p1e

	nm1
2
21
2
12 
p2e

	nm2
2
22
2
22 ,
wherem1 andm2 are themode values of Gaussians,1 and2 are the SDs
of correspondingmodes, n is the value of electrical current, and p1 and p2
are the fitting constants. The channel conductance was calculated asG
(m2m1)/Vm.
The Newton–Raphson iteration method was used to obtain the value
of nmin, which is the value of n at theminimumpoint of the function F in
the intervalm1 nm2. This was taken as the point of channel closure.
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Since the signal was digitized at 10 kHz (i.e., at intervals of 0.1 ms), the
average open time (in milliseconds) was calculated as follows (the factor
of 10 in the denominator is to account for the 0.1 ms interval):
T 

nnmin
nmax
F	n

10 	 N
,
where nmax 2m2 nmin.
All calculations were performed using the Wolfram Mathematica 6.2
software; the general algorithm of histograms construction and interpre-
tation was adapted from Bennett and Kearns (2000). We compared re-
sults obtained using this method against those obtained by averaging all
the threshold-detected openings for the data shown in Figure 3. There
was no difference between these two methods (Pearson’s correlation
coefficient of 0.992 for open time, and 0.979 for conductance).
Drugs and reagents
GABA receptor antagonists and concanamycin were purchased from
Tocris Bioscience. Other reagents were from either Ascent Scientific or
Sigma-Aldrich.
In vivo microdialysis
Animals.Male Sprague Dawley rats (Harlan) were housed three per cage
under standard housing conditions (lights on between 5:00 A.M. and
7:00 P.M.; 21–22°C; 50–60% relative humidity) with free access to food
pellets and drinking water. Animals were handled daily (5 min/rat)
starting 1 week before surgery and continuing until the day of the inser-
tion of themicrodialysis probe. At the time of surgery, rats weighed240
g. Surgical procedures were performed under isoflurane (Merial Animal
Health) anesthesia. Carprofen (Rimadyl, 4 mg/kg, s.c.; Pfizer) was ad-
ministered for postoperative pain relief. All procedures were conducted
in accordance with the United Kingdom’s Animals (Scientific Proce-
dures) Act 1986, and all efforts were made to minimize animal numbers
and suffering.
Surgical and microdialysis procedures.Nine days before the start of the
experiment, rats were surgically prepared for microdialysis of the hip-
pocampus by stereotaxic implantation of a guide cannula (MAB 6.14.IC,
Microbiotech/se AB) essentially as described in detail before (Droste et
al., 2008). After surgery, rats were housed individually in Plexiglas cages
(length  width  height  27  27  35 cm) under similar housing
conditions as described above.
Seven days after surgery, a microdialysis probe (polyethersulfone
membrane, length 4 mm, 15 kDa cutoff, and outer diameter 0.6 mm;
MAB6.14.4,Microbiotech/se AB)was inserted via the guide cannula into
the CA3–dentate gyrus region of the hippocampus (Linthorst et al.,
1994) under short-lasting isoflurane anesthesia (see Fig. 3C, schematics).
Rats were connected to a liquid swivel and a counterbalance arm (Micro-
biotech/se AB), allowing free movement in all directions. Fluorethylene
polymer tubing with a dead volume of 1.2l per 100mm length (Micro-
biotech) was used for all connections. Dead volumes were accounted for
during the experiment. Microdialysis probes were perfused with sterile,
pyrogen-free Ringer solution (Delta Pharma) at a flow rate of 2 l/min
using a micro-infusion pump (KDS220, KD Scientific).
The zero-net-flux experiment was started at 9:00 A.M. on the second
day after the insertion of the microdialysis probe. Ten minute samples
were collected throughout the complete experiment. After 1 h of baseline
sampling,microdialysis probes were subsequently perfusedwith increas-
ing concentrations of GABA (10, 20, 40, 80, 160 and 240 nM; Sigma-
Aldrich) dissolved in Ringer solution (reverse microdialysis). Each
GABA perfusion lasted 40 min during which four 10 min samples were
collected. Microdialysis samples were collected using an automated, re-
frigerated fraction collector (CMA470, CMAMicrodialysis AB) andwere
stored at80°C for later HPLC analysis.
Histology.At the end of the experiment, rats were killed using an over-
dose of pentobarbital (Euthatal, 200 mg/kg body weight, i.p.; Merial
Animal Health), and the brains were removed and stored in a 4% buff-
ered paraformaldehyde solution. Histological examination was per-
formed as described previously (Linthorst et al., 1994; Droste et al.,
2008). Only data from rats with correctly placed microdialysis probes
were included in the analyses.
Measurement of GABA. HPLC with electrochemical detection was
used to measure GABA in the microdialysates essentially as described
previously with small modifications (de Groote and Linthorst, 2007).
Briefly, GABA was separated on a TARGA C18 10 cm  1 mm column
(particle size 3 m; Higgins Analytical) using filtered and degassed mo-
bile phase (18% methanol, 0.1 M NaH2PO4, 0.2 mM EDTA, pH 4.72)
pumped at 50l/min using an Alexys LC-100 pump (Antec Leyden BV).
Standards and samples were injected onto the column using a thermo-
statically controlled (8°C) Alexys AS-100 autosampler (Antec Leyden
BV). Before injection, 13l of standard or sample was derivatized with 2
l of o-phthaldialdehyde (OPA)/sulfite solution (1.6 mM OPA, 0.5%
methanol, 1.88 mM Na2SO3, 11.25 mM Na2B4O7) for 4 min to make
GABA electrochemically active. Next, 10 l of the derivatized mixture
was injected onto the column and GABA was detected using a VT-03
electrochemical flow cell (Antec Leyden BV) set at850 mV against an
Ag/AgCl reference electrode. Both column and detector were housed in a
Faraday-shielded oven (DECADE II, Antec Leyden BV) thermostatically
controlled at 38°C. Chromatograms were recorded and analyzed using
Alexys chromatography software (Antec LeydenBV). The detection limit
forGABA at a signal-to-noise ratio of 3:1was 11–15 fmol per injection on
column.
Calculations. Perfusion of each concentration of GABA (Cin; nM) was
performed for 40 min. However, to ensure that dialysis across the mem-
brane had reached a steady state, the first 10 min sample was discarded
and only the three subsequent samples were used for the calculations
described below.
After measurement of the concentration of GABA in the collected
samples (Cout; in nM), the difference between Cout and Cin (i.e., the net
loss or gain of GABA in the dialysate) was calculated (Cout Cin; in nM)
for each concentration of GABA perfused. The baseline condition repre-
sented Cin 0. Next, for each individual animal, Cout Cin was plotted
against Cin and, after regression analysis (GraphPad 5.0), the concentra-
tion of zero-net-flux was determined as the concentration ofCin at which
CoutCin 0.Next, themean zero-net-flux concentration (SEM; n
5) was calculated. For graphical purposes, the mean  SEM values for
CoutCin were calculated for each concentration of GABA perfused and
were plotted against Cin (see Fig. 3D).
Statistics
Statistical comparisons were made using paired and unpaired (as indi-
cated in the text/figure legends) Student’s t test, and Wilcoxon signed
ranks test (Fig. 1C, experiments). Differences were considered significant
at p 0.05.Data are presented in the text and figures as themean SEM.
Results
Tonic activation of GABAARs in DGCs does not require
synaptically released GABA
Since the accumulation of GABA in the extracellular space may re-
sult from synaptic release, we asked whether depleting vesicular
GABA by incubating hippocampal slices in the vesicular H-
ATPase inhibitor concanamycin (0.5 M) would affect tonic cur-
rents.Weconfirmed that concanamycin abolished synaptic currents
(Rossi et al., 2003); however, it had no significant effect on themag-
nitude of the tonic current revealed by application of the GABAAR
antagonist picrotoxin. Application of picrotoxin produced a 11.9
1.5pAoutward shift in the Ihold in control experiments, anda13.3
3.0 pA shift when slices were preincubated in concanamycin (Fig.
1A). These results indicate that in acute hippocampal slices tonic
currents inDGCs are not dependent on the concentration of GABA
in vesicles or on GABA release into the synapse under baseline
conditions. Glycine receptors can contribute to inhibition in the
hippocampus and may also be blocked by picrotoxin in a use-
dependent manner (Danglot et al., 2004; Yang et al., 2007). We
tested their contribution by adding the glycine receptor antagonist
strychnine (1M) and observed that it had no effect on Ihold and did
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not occlude the effect of picrotoxin (Ihold following application of
strychnine:0.8 0.8 pA, n 5, p 0.40 compared with control;
consecutive application of picrotoxin: 15.6  3.3 pA, n  4, p 
0.018 comparedwith strychnine).We further ruledout thepotential
contribution of GABACRs to picrotoxin-induced shift in Ihold by
applying theGABACantagonistTPMPA(50M),whichalsodidnot
affect the amplitude of the picrotoxin-sensitive tonic current (Ihold
following application of TPMPA:0.14 1.78 pA, p 0.9 com-
pared with control; picrotoxin: 11.7 1.7 pA, p 0.006 compared
with TPMPA; n 4). Thus, we conclude that neither glycine recep-
tors nor GABACRs contribute to tonic conductance revealed by
picrotoxin.
Figure 1. Pharmacology of the GABAAR-mediated tonic currents in DGCs. A, Concanamycin (0.5M) blocks exocytosis but does not affect Itonic. No significant difference between the change in
Ihold or RMS noise in control (left trace, n 9) and concanamycin-treated slices (right trace, n 6) upon application of picrotoxin (PTX; 100M). B, Itonic in DGCs is insensitive to SR95531 and
abolished by picrotoxin. SR95531 (0.5M) partially inhibited sIPSCs,while high concentrations (125M) completely abolished sIPSCs. Picrotoxin induced an outward shift in Ihold ( p 0.0049;n
5) and decreased RMS noise ( p 0.0012; n 5). C, In the presence of GABA (5M), application of SR95531 (0.5M) reduced sIPSCs, induced an outward shift in Ihold ( p 0.016), and decreased
RMS noise ( p 0.008; n 8). SR95531 (25M) abolished sIPSCs, induced a further nonsignificant shift in Ihold ( p 0.44), and RMS noise ( p 0.06; n 5). SR95531 (125M) affected neither
Ihold nor RMS noise. Subsequent application of picrotoxin produced an outward shift in Ihold and reduced RMS noise ( p 0.031 and p 0.003 respectively; n 6). D, BMI (10M) blocked all
synaptic activity, induced an outward shift in Ihold and reduced RMS noise ( p 0.00019 and p 0.0014 respectively; n 6). SR95531 (25M) resulted in inward current and an increase in RMS
noise ( p 0.0013 and p 0.008 respectively; n 6), which were reversed by picrotoxin (100M) ( p 0.0019 and p 0.0048 respectively; n 5). Statistical comparisons were made using
pairedStudent’s t test inA,B, andD, andWilcoxon signed ranks test inC. *p0.05; **p0.01; ***p0.001.Ihold andRMSnoise values represent changes fromthepreviousdrugapplication.
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Tonic currents in DGCs are insensitive to SR95531 under
baseline conditions
These results suggest either that [GABA]e is maintained at a con-
stant concentration despite decreased vesicular GABA release
(e.g., by nonvesicular release) and/or that there is another mech-
anism involved in generating tonic currents that is independent
of [GABA]e.
To distinguish between these possibilities, we took advantage
of the distinct pharmacologies of different GABAAR antagonists.
Picrotoxin is an open channel blocker and acts as a noncompet-
itive GABAAR antagonist that has equivalent efficacy in blocking
low-affinity synaptic and high-affinity extrasynaptic GABAARs
(Stell and Mody, 2002). In contrast, SR95531 is a competitive
GABAAR antagonist and displaces GABA from its binding site
(Hamann et al., 1988).While low concentrations of SR95531 (0.5
M) partially inhibited and high concentrations (125 M) totally
blocked sIPSCs, there was no significant increase in Ihold, which
became more negative at high SR95531 concentrations (Ihold,
6.7 1.6 pA, n 5, p 0.014 compared with 0.5 M SR95531;
Fig. 1B; Table 1), suggesting a partial agonist effect (this effect
was not observed when SR95531 was applied after picrotoxin:
Ihold,1.2 0.9 pA, n 3, p 0.3). Subsequent application
of picrotoxin resulted in an outward shift of Ihold by 18.9 3.4
pA (p 0.0049, n 5), and a decrease in baseline RMS noise
by 0.39  0.05 pA (p  0.0012, n  5) in the same cells (Fig.
1B). This effect of picrotoxin was occluded by prior applica-
tion of pentylenetetrazol (Table 1), another noncompetitive
GABAAR antagonist (Huang et al., 2001). Ihold following ap-
plication of picrotoxin in the presence of pentylenetetrazol
was 0.4  0.7 pA (n  5).
As previously reported (Semyanov et al., 2003), markedly in-
creasing GABA in the perfusate to 5 M revealed a SR95531-
sensitive component of the tonic current (Fig. 1C). Under these
conditions, application of a low concentration of SR95531 (0.5
M) caused a significant outward shift of 29.4  14.4 pA in the
holding current (p 0.016, n 8) and a significant decrease in
RMSnoise by 3.0 0.8 pA (p 0.008,n 8, Fig. 1C). Even in the
presence of a high concentration of SR95531 (125 M) under
these conditions, application of picrotoxin caused a further out-
ward shift in holding current by 9.2 2.1
pA (p 0.031, n 6) and a reduction of
RMS noise by 0.51 0.09 pA (p 0.003,
n 6; Fig. 1C).
The lack of efficacy of SR95531 under
baseline conditions suggests that only
negligible ambient GABA can be detected
by dentate granule cells. Alternatively,
SR95531 may not bind to the receptors
mediating tonic current. The efficacy of
SR95531 in expression systems in which
4 subunit-containing receptors (the
main contributor to tonic currents in den-
tate granule cells) (Glykys and Mody,
2007b) are expressed (Brown et al., 2002)
argues against this. Nevertheless, we tested
thisusinganothercompetitiveGABAARan-
tagonist, bicuculline. Application of bicuc-
ulline (10 M) blocked all synaptic activity,
induced a small outward shift of holding
current by 5.9 0.6 pA (p 0.00019, n
6), and decreased baseline RMS noise by
0.720.11pA (p0.0014,n6; Fig. 1D).
This result can be explained by the inverse
agonist activity of bicuculline (Ueno et al., 1997; Bai et al., 2001;
McCartney et al., 2007). If SR95531 does not bind to the same re-
ceptors as bicuculline, then it should have no effect in the pres-
ence of bicuculline. Conversely, if SR95531 does bind then it
should displace the bicuculline and paradoxically induce an in-
ward current. The effect of bicuculline was indeed reversed by
application of SR95531 (25 M), which activated an inward cur-
rent of 10.7 1.7 pA (p 0.0013, n 6), and increased baseline
noise by 0.27 0.06 pA (p 0.008, n 6). This was completely
blocked by subsequent application of picrotoxin (Fig. 1D). These
results suggest that all three GABAAR antagonists bind to the
same receptors and that these receptors are not detecting GABA
under baseline conditions. Moreover, the lack of effect of
SR95531 in baseline conditions indicates that other possible en-
dogenous agonists (e.g., taurine) are also not mediating the tonic
current (Jia et al., 2008).
SR95531-insensitive tonic currents in DGCs are mediated by
not only  subunit-containing GABAARs
Tonic GABAAR-mediated currents in DGCs are predominantly
mediated by 4 and  subunit-containing receptors (Stell and
Mody, 2002; Stell et al., 2003; Caraiscos et al., 2004).We therefore
tested whether -GABAARs contribute to the SR95531-resistant
tonic current. We took advantage of knock-out mice lacking 
subunits of GABAARs. In thesemice, in contrast to rats, there was
a very small SR95531-sensitive tonic current. However, the ma-
jority of the tonic current was SR95531 insensitive (Fig. 2). In
/mice in the presence of 25 M SR95531, the effect of picro-
toxin on holding current was 60% less than that in wild-type
mice (littermate controls), implying that -GABAARs contrib-
Figure 2. -Subunit-containing GABAA receptors are involved in generating picrotoxin-sensitive tonic currents in DGCs. The
effects of SR95531 (25M) andpicrotoxin (PTX, 100M) onholding currents recorded inwild-type (top trace) and knock-outmice
lacking -subunit-containing GABAARs (bottom trace). Picrotoxin-sensitive tonic currents are reduced in the knock-out mice
compared with the wild-type littermate controls (n 9 and n 10 for the / and /mice, respectively; **p 0.01,
Student’s unpaired t test). Histogram shows mean values SEM.
Table 1. The effect of different GABA antagonists in control conditions with no
GABA added
Antagonist GABA tonic current (Ihold , pA)
PTX (100M) 11.9 1.5, n 9, p 0.00004 compared to control
Pentylenetetrazol (1.5 mM) 10.6 3.6, n 5, p 0.04 compared to control
Bicuculline (10M) 5.9 0.6, n 6, p 0.0002 compared to control
SR95531 (125M) 6.7 1.6, n 5, p 0.01 compared to control
PTX (100M) in SR95531 (125M) 18.9 3.4, n 5, p 0.005 compared to SR95531
(125M)
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ute to SR95531-resistant tonic currents
(Fig. 2). However, there was a significant
SR95531-insensitive tonic current in /
mice, suggesting that other GABAAR
subtypes can also contribute to the
SR95531-insensitive tonic current in DGCs
(Glykys et al., 2008).
Low [GABA]e is maintained both in
vitro and in vivo
The fact that DGCs display SR95531-
insensitive tonic currents suggests that
[GABA]e in ex vivo tissue is maintained at
concentrations that are not detectable by
high-affinity GABAARs.
We used GABAAR openings in outside-
out “sniffer” patches fromdentate granule
cells (Fig. 3A,B) to give a semiquantitative
estimate of [GABA]e in slices. We first
confirmed that channel openings could be
recorded in outside-out patches in the
presence of 10 M GABA (channel open-
ings disappeared in the absence of GABA)
(Fig. 3A). These channels were blocked by
picrotoxin and had an opening frequency
of 20.1 5.6 Hz, a conductance of 39.4
7.2 pS, and an average open time of 32.1
7.1 ms (n  11). We were able to detect
GABAAR openings when the patch was 5
m above the slice (0.55  0.05 Hz, n 
5), indicating that there is sufficient extra-
cellular GABA to bind to GABAARs (Fig.
3B). These openings did not occur when
the patch was moved 300 m above the
slice and recurred on lowering the patch
again to the slice (Fig. 3B). Consequent
application of 200 nM GABA to the per-
fusate, comparable to that found in CSF
(Glaeser andHare, 1975), almost doubled
the frequency of GABAAR openings re-
corded above the slice surface. The effect
of 200 nM GABA application was even
more evident when patches were raised
300mabove the slice. This indicates that
[GABA]e is200 nM in the slice (Fig. 3B)
and is consistentwith the predictedGABA
transporter equilibrium [GABA]e of 100
nM (Wu et al., 2007). We further con-
firmed that similarly low [GABA]e is
maintained in vivo by using the zero-net-
flux microdialysis method. Microdialysis
probes were inserted into the CA3-
dentate gyrus region via guide cannula,
and in vivo [GABA]e was calculated to be
92 10 nM (n 5; Fig. 3C,D).
Since an increase inGABAARopenings
occurs as the patch approaches the sur-
face, yet there is no evidence of significant
GABA-medicated tonic currents, it is
likely that the activity of GABA transport-
ers prevents extrasynaptic GABAA recep-
tors from being exposed to even such low
concentrations under baseline condi-
Figure3. LowextracellularGABAconcentration in vitroand in vivo.A, Snifferpatches, outside-outpatches fromDGCs,displayGABAAR
channel openings in the presence of GABA. Representative traces are shown on the left panel. Top, Application of 10M GABA to the
outside-outpatches inducessingle-channelopenings.Middle,Ablow-upofthesectionofthetoptracemarkedbytheverticaldashedlines.
Bottom, A trace illustrating no channel activity in the absence of GABA in perfusion solution. Right, Normalized all-points amplitude
histogram from the experimentwith 10MGABAapplication. Horizontal lines indicatemeanamplitude values of anopen (O) and closed
(C)state.B,Thefrequencyofchannelopeninginthesnifferpatchclosetotheslicesurface(5maboveDGClayer)andinthebath(300m
abovetheslice surface)withandwithout200nMGABAintheperfusionsolution(sample traces fromthesamepatchatdifferentconditions
are shownonthe left). Bar charts show(fromtop tobottomonthe right)normalizedvaluesof channelopening frequency,open time,and
conductance SEM (n 5; *p 0.05; **p 0.01; ***p 0.001, paired Student’s t test). C, Estimation of [GABA]e in the rat
hippocampuswasperformedusingzero-net-fluxmicrodialysis. Locationsof themicrodialysisprobes in thehippocampus fromfive ratsare
shown by the black circles on the schematic of a horizontal section of rat brain (Paxinos andWatson, 2007).D, After the collection of six
baseline samples, themicrodialysis probewas perfusedwith increasing concentrations of GABA (Cin; 10–240 nM) by reverse dialysis. The
baseline condition represents Cin 0. The concentration of GABA in the collected samples (Cout; in nM) was determined by HPLC with
electrochemical detection. The net loss or gain of GABA in the dialysate (Cout Cin; in nM)was calculated andplotted against the concen-
tration of GABA in the perfusion fluid (Cin). The intercept with the dashed line ( y 0) is the concentration of GABA at which Cout Cin
represents an estimate of the [GABA]e (n 5).
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tions. When GABA in the perfusate was increased to 200 nM,
comparable to that found in CSF (Glaeser and Hare, 1975), Ihold
did not change significantly and SR95531 (25 M) had no signif-
icant effect on Ihold (Ihold following consequent application of
GABA: 1.21  2.03 pA, p  0.6; Ihold following consequent
application of SR95531: 1.7 1.4 pA, p 0.29; n 5), indicating
that there is no increase in the GABA detected by extrasynaptic
GABAARs.
Spontaneously opening GABAARs in DGCs
The evidence thus far implies that tonic inhibition inDGCs in situ
is predominantly GABA independent. Can tonic currents be me-
diated by spontaneously openingGABAARs? Such receptors have
been reported in excised patch and cell-attached recordings from
hippocampal neurons (Birnir et al., 2000a), but not in the DGCs
(Birnir et al., 1994). Failure to detect spontaneously opening
GABAARs may be due to the small area sampled using outside-
Figure 4. Spontaneous GABAAR channel openings in nucleated patches. A, Left, Representative traces illustrating single-channel openings; top to bottom: control, SR95531 (25M), picrotoxin
(20 M). Lower traces are expanded segments indicated by vertical dashed lines on the top traces. Right, Normalized all-points amplitude histograms. B–D, Channel opening frequency (B),
conductance (C), and average open time (D) normalized to control values (n 5 nucleated patches). E, Application of 125M SR95531 increases the frequency of spontaneous channel openings.
Left, Sample traces. Right, Spontaneous channel opening frequency, open time, and conductance normalized to control values (n 5). Horizontal dashed lines indicate an open (O) and closed (C)
state. *p 0.05; ***p 0.001, paired t test. W/O, Washout.
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out patches and/or the dependence of such openings upon the
internal neuronal environment. Indeed, we noted that in very few
excised patches (10%) could we detect infrequent channel
openings (less than one every 20 s). We therefore performed
recordings fromnucleated patches (i.e., whole-cell excisions con-
taining intact nuclei). In this preparation, spontaneous GABAAR
openings were recorded in the majority of patches (Fig. 4). These
openings had a conductance (37.4  6.1 pS) similar to that ob-
served in excised outside-out patches with applied GABA (39
7.2 pS; Fig. 3A), and comparable to that determined in other
studies (Bright et al., 2011). As expected, spontaneous openings
were not affected by SR95531 (25 M) but were fully blocked by
picrotoxin (Fig. 4A–D). Since a high concentration of SR 95521
(125M)had acted as a partial agonist (Fig. 1), we tested the effect
of SR 95521 (125 M) on spontaneous openings in nucleated
patches and, as predicted, found that it increased the frequency of
openings (Fig. 4E). Addition of 10 M GABA to the nucleated
patches revealed SR95531-sensitive channels with the same con-
ductance (Fig. 5).
Discussion
Our results indicate that GABA-independent openings of
GABAARs are the major contributor to tonic currents in dentate
granule cells ex vivo, even when GABA concentrations in the
perfusate are increased to levels comparable to thosemeasured
in vivo.
We took advantage and confirmed the different pharmacolo-
gies of GABAAR antagonists (Table 1), and have shown that in
situDGC tonic currents are resistant to SR95531, indicating that
they are not being generated by GABA binding to the receptors.
This is consistent with similar observations in cultured neurons,
other brain areas and cell types (Birnir et al., 2000b;McCartney et
al., 2007). Importantly, SR95531 has a paradoxical effect of in-
hibiting the action of the inverse agonist bicuculline. This result
suggests that SR95531 is displacing bicuculline from the recep-
tors and consequently that the lack of effect of SR95531 is not due
to a failure to bind to the receptors that are mediating the tonic
current. At high concentrations (125 M), we also found that
SR95531 can act as a partial agonist. A partial agonist effect of
SR95531 (100 M) and bicuculline (1 mM) has been described
previously at GABAARs in which there is a point mutation in the

 subunit (Ueno et al., 1997). We did not test bicuculline at this
concentration and so cannot exclude a partial agonist effect of
very high concentrations of bicuculline at extrasynaptic
receptors.
This lack of GABA binding explains why inhibiting vesicular
GABA release in our studies has no effect on the tonic current.
The low concentration of GABA despite vesicular release is al-
Figure 5. Application of GABA to nucleated patches from dentate granule cells induces SR95531-sensitive channel openings. A, Left, Representative traces illustrating single-channel openings
at consecutive stages of the experiment performed in the presence of 10M GABA. From top to bottom: control, SR95531 (25M), washout of SR95531. Horizontal dashed lines indicate mean
amplitude values of an open (O) and closed (C) state. Right, Normalized all-points amplitude histograms. B–D, Normalized average opening frequency (B), conductance (C), and open time (D) of
channel openings induced by GABA application (n 5 nucleated patches). **p 0.01, ***p 0.001, paired Student’s t test. W/O, Washout.
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most certainly due to efficient GABA uptake, because, when
GABA transporters are blocked, tonic currents become depen-
dent upon vesicular GABA release (Glykys and Mody, 2007b).
The effect of decreasing vesicular release has variable results de-
pending upon the nature of the tissue studied, suggesting that
GABA concentrations and the consequent detection of extracel-
lular GABA by GABAARs vary between brain regions. For exam-
ple, in thalamocortical neurons, 50 M SR95531 has been
demonstrated to reveal robust tonic GABAAR-mediated currents
(Cope et al., 2005). There may even be local inhomogeneities of
GABA concentrations due to regional differences in the distribu-
tion of GABA transporters (Semyanov et al., 2003). Indirect evi-
dence of this in the hippocampus is supplied by the observation
that tonic currents are reduced in CA1 interneurons, but not in
pyramidal cells of GAD65-deficient mice (Song et al., 2011).
However, whether the heterogeneity of extracellular GABA con-
centrations observed in vitro occurs in vivo is unclear.
Spontaneous openings of GABAARs have been previously de-
scribed in some preparations (e.g., in isolated hippocampal py-
ramidal cells and in outside-out patches from pyramidal
neurons, but not in DGCs). However, the role for these sponta-
neous openings, and whether they can contribute to GABAAR-
mediated signaling in situ, has remained unclear (Macdonald et
al., 1989; Birnir et al., 2000b). Here, we recorded from nucleated
patches to show directly that spontaneously opening receptors
are present in dentate granule cells. As predicted fromother stud-
ies (McCartney et al., 2007), they are not affected by the compet-
itiveGABAAR antagonist SR95531 and are completely blocked by
the open channel blocker picrotoxin. Lack of evidence of such
openings in outside-out patches from dentate granule cells in
previous studies may be related both to the small area of mem-
brane and also to the effects of the internal cellular milieu on
GABAAR channel gating.
A vexed question is how GABA in a slice relates to the in vivo
situation. Direct measurements of GABA in CSF have revealed
concentrations on the order of 200 nM (Glaeser and Hare, 1975).
Using the zero-net-fluxmicrodialysismethod, we have estimated
the concentration in the extracellular fluid to be even lower. This
is somewhat at odds with an earlier study that estimated the
GABA concentration in the extracellular fluid of the hippocam-
pus to be 800 nM (Lerma et al., 1986). This measurement, how-
ever, was confounded by the complex method used to retrieve
absolute concentrations from dialysate concentrations and reli-
ance on estimates of diffusion across the dialysis membrane. It
should also be noted that these previous estimates were per-
formed in rats under urethane anesthesia, and sampling was per-
formed 1 h after probe implantation, when the blood–brain
barrier could still be disrupted. The microdialysis method aver-
ages over a large area, and so we cannot exclude the possibility
that the regional GABA concentrations may differ and, in partic-
ular, that the concentration detected by neurons may be greater
than this depending upon the balance of local release and uptake;
however, this was not observed by us (and others) using the
sniffer patch technique. Indeed, 100 nM is close to the EC20 for
extrasynaptic -subunit-containing GABAARs (Bright et al.,
2011), and so the absence of a detectableGABA-mediated current
under baseline conditions or when GABA in the perfusate is in-
creased to 200 nM indicates that the GABA detected by neurons is
less than that present in the extracellular space, perhaps due to
efficient local GABA uptake. These results strongly argue against
the widespread addition of high GABA concentrations (usually 5
M) to the perfusate during ex vivo experiments. Indeed, these
concentrations of GABA are 50-fold greater than those we detect
in vivo.
Our findings have several important implications. First, our
results indicate that studies that use SR95531 to measure tonic
currents may significantly underestimate them. The results may
also explain discrepancies in the measurement of tonic currents
in DGCs, which in one study (and in contrast to others) was
proposed not to be present in control tissue because of the lack of
effect of SR95531 (Zhan and Nadler, 2009). Furthermore, the
widespread use of SR95531 and on occasion high concentrations
of SR95531, which could have a partial agonist effect, may signif-
icantly underestimate the magnitude of tonic currents present.
Even when GABA is gating the receptor, displacement by
SR99531 would not prevent spontaneous openings, and may
therefore not accurately measure the tonic current. Moreover,
our results indicate that there is always a tonic current present in
dentate granule cells even when extracellular GABA concentra-
tions are low (as they are most of the time). The importance of
maintaining such an inhibitory tone in neurons is further under-
scored by the observation that knocking out receptors generating
tonic current in cerebellar granule cells leads to an upregulation
of a two-pore potassium channel to maintain the conductance
(Brickley et al., 2001).
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